Valneva appoints peter buhler as chief financial officer

Saint- herblain (france), july 29 , 2021 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced the appointment of peter buhler as chief financial officer (cfo) and management board member.
VALN Ratings Summary
VALN Quant Ranking